ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Michigan » Nephrology

Top Nephrology Prescribers in Michigan

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MONA DOSHI MD

Nephrology

8,707

$816K

185
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 27%

$94
Average prescription price

Avg: $138

MARJORIE FUNTANILLA MD

Nephrology

7,329

$552K

340
244 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 27%

$75
Average prescription price

Avg: $138

TALANKI VISWANATH M.D.

Nephrology

7,127

$576K

412
359 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 27%

$81
Average prescription price

Avg: $138

MARK BOELKINS MD

Nephrology

5,709

$482K

340
126 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 27%

$84
Average prescription price

Avg: $138

GREGORY DOWNER M.D.

Nephrology

5,597

$645K

543
326 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 27%

$115
Average prescription price

Avg: $138

ADEEL KHAN M.D.

Nephrology

4,920

$705K

487
349 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 27%

$143
Average prescription price

Avg: $138

DANIEL AZABACHE MD

Nephrology

4,857

$454K

354
296 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 27%

$93
Average prescription price

Avg: $138

JEROLD NAPIER MD

Nephrology

4,818

$486K

315
230 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 27%

$101
Average prescription price

Avg: $138

JON HIMES MD

Nephrology

4,437

$369K

254
189 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 27%

$83
Average prescription price

Avg: $138

RICHARD KAMMENZIND M.D.

Nephrology

4,368

$425K

274
231 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 27%

$97
Average prescription price

Avg: $138

SHOAIB CHOWDHURY MD

Nephrology

4,310

$417K

496
357 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 27%

$97
Average prescription price

Avg: $138

KRISHNAPILLAI THAVARAJAH MD

Nephrology

3,859

$486K

245
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 27%

$126
Average prescription price

Avg: $138

ABDUL EFFENDI MD

Nephrology

3,564

$568K

210
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

17%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 27%

$159
Average prescription price

Avg: $138

STEPHEN MIGDAL MD

Nephrology

3,462

$679K

173
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 27%

$196
Average prescription price

Avg: $138

GEEORGE ADAM M.D.

Nephrology

3,418

$510K

247
168 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

20%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 27%

$149
Average prescription price

Avg: $138

CRYSTAL GARDNER-MARTIN MD

Nephrology

3,285

$394K

209
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 27%

$120
Average prescription price

Avg: $138

ROBERT MICHAELS M.D.

Nephrology

3,253

$433K

257
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 27%

$133
Average prescription price

Avg: $138

MAKHOUL HOURANI MD

Nephrology

3,187

$258K

308
258 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 27%

$81
Average prescription price

Avg: $138

MANOHAR ATRI MD

Nephrology

3,126

$203K

109
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

44%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 27%

$65
Average prescription price

Avg: $138

FAHD AL-SAGHIR MD

Nephrology

3,042

$517K

212
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 27%

$170
Average prescription price

Avg: $138

JERRY DANCIK MD

Nephrology

3,042

$352K

312
231 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 27%

$116
Average prescription price

Avg: $138

DANIEL BRASH M.D.

Nephrology

3,007

$340K

326
230 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 27%

$113
Average prescription price

Avg: $138

BAO-MIN TWU MD

Nephrology

2,997

$286K

470
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

17%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 27%

$95
Average prescription price

Avg: $138

PETER MANRING MD

Nephrology

2,907

$199K

362
265 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 27%

$68
Average prescription price

Avg: $138

MARK STANIFORTH MD

Nephrology

2,837

$259K

447
253 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 27%

$91
Average prescription price

Avg: $138

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank